A
Amryt Pharma
Biotech & Life Sciences · Dublin, Ireland · Founded 2004 · IPO 2012 Unicorn
Global footprint
Where Amryt Pharma has talent and traffic
team presence
across markets
Patent intelligence
$184M patent portfolio · 53 active families
Where Amryt Pharma concentrates vs peers
Each axis is a top-10 topic across Amryt Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Amryt Pharma's 4 investments and acquisitions.
Every disclosed deal where Amryt Pharma appeared as a backer or acquirer, 2016–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Amryt Pharma's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Amryt Pharma's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Amryt Pharma
An AI-synthesized read of the highest-engagement posts about Amryt Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Amryt Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.